Screening for Anal Cancer and Precancer in Women With HIV (SANCA)

NANot yet recruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2035

Conditions
Anal Canal Cancer
Interventions
DIAGNOSTIC_TEST

anal HPV screening

From all included women samples will be collected at the out-patient HIV departments including self-sampled vaginal swab for hrHPV testing and self-sampled anal swab for hrHPV. A blood sample will be taken for the analysis of circulating HPV DNA.

Trial Locations (1)

Unknown

Karolinska Institutet, Stockholm

All Listed Sponsors
collaborator

Karolinska University Hospital

OTHER

collaborator

Stockholm South General Hospital

OTHER

collaborator

Sahlgrenska University Hospital

OTHER

collaborator

The Swedish Research Council

OTHER_GOV

lead

Karolinska Institutet

OTHER